RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Stockholders' equity

AbbVie Inc.ABBV

Market cap
$405.4B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 20243,364-67.64%
Dec 31, 202310,397-39.86%
Dec 31, 202217,287+11.99%
Dec 31, 202115,436+17.86%
Dec 31, 202013,097-260.27%
Dec 31, 2019-8,172-3.24%
Dec 31, 2018-8,446-265.71%
Dec 31, 20175,097+9.94%
Dec 31, 20164,636+17.52%
Dec 31, 20153,945+126.46%
Dec 31, 20141,742-61.22%
Dec 31, 20134,492

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)